Opinercept
Opinercept is a recombinant fusion protein comprising an TNFRSF1B fused to a human IgG1 Fc[1]. Opinercept is a tumor necrosis factor-alpha (TNF-alpha) inhibitor. Opinercept can be used for the research of rheumatoid arthritis (RA) [1].
Product Specifications
CAS Number
2055118-96-0
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/opinercept.html
Solubility
10 mM in DMSO
Smiles
[Opinercept]
References & Citations
[1]Liang TH, et al. Efficacy and Safety of Opinercept Tumor Necrosis Factor Inhibitor Therapy for Drug-Refractory Rheumatoid Arthritis: A Randomized Clinical Trial. Arch Rheumatol. 2020 Jan 8;35 (2) :170-179.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog